18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.
about
The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapyMultimodality and nanoparticles in medical imagingMeta-DiSc: a software for meta-analysis of test accuracy data.18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scaleUsefulness of (18)F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Patients with High-Grade Non-Hodgkin's Lymphoma.Volume and attenuation computed tomography measurements for interim evaluation of Hodgkin and follicular lymphoma as an additional surrogate parameter for more confident response monitoring: a pilot studyHodgkin's lymphoma therapy: past, present, and future.Correlation of tissue biopsy and fine needle aspiration cytology with positron emission tomography results.The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.PET in lymphoma.18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell LymphomaDual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.PET/CT in oncology: for which tumours is it the reference standard?The utility of body FDG PET in staging primary central nervous system lymphomaThe role of fluorodeoxyglucose positron emission tomography-computerized tomography in resolving therapeutic dilemmas in pediatric Hodgkin lymphomaPrognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria.Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-upIncorporating prognostic imaging biomarkers into clinical practice.Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma.A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario.FDG-PET imaging in hematological malignanciesWhole-body diffusion-weighted imaging for staging malignant lymphoma in children.Current status of PET/CT in the diagnosis and follow up of lymphomas.Predicting tumour response.Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma.The role of FDG-PET in Hodgkin lymphomaFDG-PET in Follicular Lymphoma ManagementMetabolic tumor volume on interim PET is a better predictor of outcome in diffuse large B-cell lymphoma than semiquantitative methodsSpecialized second-opinion radiology review of PET/CT examinations for patients with diffuse large B-cell lymphoma impacts patient care and management.
P2860
Q26863624-D5C8259E-2C22-4741-BA3E-E2C53F61FFCCQ30407070-246D49FE-F3D3-4E6B-8A52-72C1518FFB49Q31048578-6BBDB254-BDCB-4B05-991D-5BD1DEEE5F4CQ33606294-7E714D66-73B0-4712-936C-0550A35F4F97Q33696003-E07430E8-6F77-4392-BBEC-665132BBC880Q33704669-853F877C-9C95-4BE2-B142-343B0E5E20BFQ34063323-65C2E23B-F33F-4E52-8E02-EC2E6D05FC67Q34296914-6D9E20B9-9FF0-48E6-947D-789C23F47B5BQ34954095-01CBF6E2-1228-4F4A-884D-BC479D412A95Q35032285-EB8D56EA-DC9D-4D3A-8E7D-0CBF060EDD0DQ35650641-F38C5C69-E8F4-4292-BFA3-BD9241F67079Q35855599-17CD70BE-A6C3-4DB2-87B9-D195290135ADQ36618941-32BDB417-53A8-4303-B78B-4EADA5700B54Q36816955-F6507779-0E4B-4E55-811E-3F609C9F0F4EQ36963748-78E4473B-76CF-4257-8DA4-AA71DB718C47Q37036944-4964222C-127E-4B14-9C12-C6D5EE4DED50Q37058257-0EE50AAE-FC2D-43AF-A9B0-EFA7A131272CQ37077176-A2B77034-A0E9-4159-86B5-CB5EE6123146Q37146056-08AA142A-E352-4A02-A6D6-BFDA7835CE2BQ37193816-9C334200-0BE4-4FDC-A229-2F97FC7AF182Q37240835-9398E099-AE65-4EBE-AC25-57CCEE7050CBQ37307649-3E6FF3D9-7089-46C1-B025-FB2AE6F538A3Q37428422-95D69F5D-07A5-4221-8D0A-B44AB5618290Q37632114-0CCC71B0-EDBE-4C58-BBC1-A2D6681C0B17Q37777048-D0237160-F6B7-4B22-B6A0-495E1CBA2041Q38071295-59C2C3DF-17F9-47D0-A535-988482DD0D8EQ38141699-31D53666-097B-4326-ADFD-F43967F9F188Q41573147-4588000B-A590-447A-8BDA-2D4A3D4117CFQ41691698-AEEA51AD-7463-4674-AA99-C8E6A5BE6EB3Q41840128-950EE9A2-9673-49A6-9235-CEC39E96E268Q42421867-2D104C08-C2ED-43E5-8938-DE352595BD0BQ49486010-4831287B-B65B-4FD5-BC95-C60A95554712
P2860
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
18F-fluoro-deoxyglucose positr ...... lymphoma: a systematic review.
@ast
18F-fluoro-deoxyglucose positr ...... lymphoma: a systematic review.
@en
type
label
18F-fluoro-deoxyglucose positr ...... lymphoma: a systematic review.
@ast
18F-fluoro-deoxyglucose positr ...... lymphoma: a systematic review.
@en
prefLabel
18F-fluoro-deoxyglucose positr ...... lymphoma: a systematic review.
@ast
18F-fluoro-deoxyglucose positr ...... lymphoma: a systematic review.
@en
P2093
P1433
P1476
18F-fluoro-deoxyglucose positr ...... lymphoma: a systematic review
@en
P2093
Gerda Lindauer-van der Werf
Ingrid I Riphagen
Josée M Zijlstra
Lotty Hooft
Otto S Hoekstra
Peter C Huijgens
P304
P577
2006-04-01T00:00:00Z